Effectiveness of an App for Tobacco Cessation in Pregnant Women (TOBBGEST)
Launched by FUNDACIO D'INVESTIGACIO EN ATENCIO PRIMARIA JORDI GOL I GURINA · Jan 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TOBBGEST clinical trial is studying the effectiveness of a mobile app designed to help pregnant women quit smoking. Tobacco use during pregnancy can harm both the mother and the baby, so this trial aims to see if using an app that makes quitting feel more like a game can encourage women to stop smoking. The researchers want to find out how well this app works compared to regular support and whether it helps women remain smoke-free in the long term.
To participate in this trial, pregnant women who smoke and are over 18 years old can sign up, as long as they have a smartphone and are comfortable using apps. Participants in the study will receive standard care for quitting smoking along with access to the app, which includes fun features to keep them motivated. Throughout the trial, researchers will check in on their progress to see how many women manage to quit smoking. This trial is important because it could lead to better tools for helping pregnant women reduce tobacco use, ultimately improving health for mothers and their babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women smokers (report having smoked sporadically or daily in the last 30 days(\*)) over 18 years of age,
- • Follow-up of pregnancy in the ASSIR in Camp de Tarragona and Barcelona of the ICS,
- • Having a mobile device with Android or iOS operating system and data connection,
- • Having skills on the use of Apps and willingness to use them (#).
- • (\*) Active smoking is defined as daily or occasional smoking in the last month, regardless of the amount smoked.
- • (#) It is understood that you have skills on the use of Apps and willingness to use them if you answer affirmatively to the following questions: Have you downloaded any application on your mobile?, Would you install an application to help you quit smoking on your mobile?, Have you participated in any chat group?, and Have you played any game with your mobile device? (criteria to ensure the usability of the intervention tool).
- Exclusion Criteria:
- • Having participated in a smoking cessation study within the last 12 months,
- • Psychiatric history that prevents or limits follow-up of the study,
- • Inability to follow up for any reason,
- • Express refusal of the patient to continue in the study.
About Fundacio D'investigacio En Atencio Primaria Jordi Gol I Gurina
The Fundació d'Investigació en Atenció Primària Jordi Gol i Gurina is a prominent research foundation dedicated to advancing primary healthcare through rigorous scientific investigation and innovation. Established to enhance the quality of primary care services, the foundation conducts clinical trials and research projects that address pressing health issues, aiming to improve patient outcomes and inform healthcare practices. Committed to collaboration and knowledge dissemination, the organization engages with healthcare professionals, academic institutions, and community stakeholders to foster a culture of evidence-based medicine and continuous improvement in primary care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Cristina Rey-Reñones, PhD
Principal Investigator
IDIAP JORDI GOL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials